ACCURAY INC (ARAY) Fundamental Analysis & Valuation

NASDAQ:ARAY • US0043971052

Current stock price

0.4166 USD
+0.05 (+12.47%)
At close:
0.4264 USD
+0.01 (+2.35%)
Pre-Market:

This ARAY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ARAY Profitability Analysis

1.1 Basic Checks

  • In the past year ARAY has reported negative net income.
  • In the past year ARAY had a positive cash flow from operations.
  • In the past 5 years ARAY always reported negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: ARAY reported negative operating cash flow in multiple years.
ARAY Yearly Net Income VS EBIT VS OCF VS FCFARAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M

1.2 Ratios

  • The Return On Assets of ARAY (-7.95%) is better than 62.50% of its industry peers.
  • ARAY has a Return On Equity (-66.68%) which is in line with its industry peers.
Industry RankSector Rank
ROA -7.95%
ROE -66.68%
ROIC N/A
ROA(3y)-1.87%
ROA(5y)-1.61%
ROE(3y)-17.92%
ROE(5y)-14.58%
ROIC(3y)N/A
ROIC(5y)N/A
ARAY Yearly ROA, ROE, ROICARAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60

1.3 Margins

  • ARAY's Operating Margin has declined in the last couple of years.
  • ARAY has a worse Gross Margin (27.83%) than 77.72% of its industry peers.
  • ARAY's Gross Margin has declined in the last couple of years.
  • ARAY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.83%
OM growth 3Y-3.19%
OM growth 5Y-12.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.86%
GM growth 5Y-3.89%
ARAY Yearly Profit, Operating, Gross MarginsARAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. ARAY Health Analysis

2.1 Basic Checks

  • ARAY does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ARAY has more shares outstanding
  • ARAY has more shares outstanding than it did 5 years ago.
  • ARAY has a better debt/assets ratio than last year.
ARAY Yearly Shares OutstandingARAY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
ARAY Yearly Total Debt VS Total AssetsARAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • ARAY has an Altman-Z score of -0.50. This is a bad value and indicates that ARAY is not financially healthy and even has some risk of bankruptcy.
  • ARAY's Altman-Z score of -0.50 is in line compared to the rest of the industry. ARAY outperforms 41.30% of its industry peers.
  • A Debt/Equity ratio of 2.34 is on the high side and indicates that ARAY has dependencies on debt financing.
  • The Debt to Equity ratio of ARAY (2.34) is worse than 83.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.34
Debt/FCF N/A
Altman-Z -0.5
ROIC/WACCN/A
WACC7.63%
ARAY Yearly LT Debt VS Equity VS FCFARAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 1.47 indicates that ARAY should not have too much problems paying its short term obligations.
  • ARAY has a worse Current ratio (1.47) than 76.09% of its industry peers.
  • ARAY has a Quick Ratio of 1.47. This is a bad value and indicates that ARAY is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.71, ARAY is doing worse than 86.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 0.71
ARAY Yearly Current Assets VS Current LiabilitesARAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ARAY Growth Analysis

3.1 Past

  • The earnings per share for ARAY have decreased strongly by -418.00% in the last year.
  • Looking at the last year, ARAY shows a decrease in Revenue. The Revenue has decreased by -3.57% in the last year.
  • ARAY shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.67% yearly.
EPS 1Y (TTM)-418%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-650%
Revenue 1Y (TTM)-3.57%
Revenue growth 3Y2.17%
Revenue growth 5Y3.67%
Sales Q2Q%-11.99%

3.2 Future

  • The Earnings Per Share is expected to grow by 83.91% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, ARAY will show a small growth in Revenue. The Revenue will grow by 2.02% on average per year.
EPS Next Y-902.41%
EPS Next 2Y-92.17%
EPS Next 3Y83.91%
EPS Next 5YN/A
Revenue Next Year-2.54%
Revenue Next 2Y0.96%
Revenue Next 3Y2.02%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ARAY Yearly Revenue VS EstimatesARAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
ARAY Yearly EPS VS EstimatesARAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -0.2 -0.4

More info and screens

Find the best growth stocksShow best growing peers

1

4. ARAY Valuation Analysis

4.1 Price/Earnings Ratio

  • ARAY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ARAY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ARAY Price Earnings VS Forward Price EarningsARAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ARAY Per share dataARAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

  • ARAY's earnings are expected to grow with 83.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-92.17%
EPS Next 3Y83.91%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ARAY Dividend Analysis

5.1 Amount

  • ARAY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ARAY Fundamentals: All Metrics, Ratios and Statistics

ACCURAY INC

NASDAQ:ARAY (3/16/2026, 8:08:04 PM)

Premarket: 0.4264 +0.01 (+2.35%)

0.4166

+0.05 (+12.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-04
Earnings (Next)04-28
Inst Owners71.01%
Inst Owner Change8.28%
Ins Owners3.74%
Ins Owner Change17.36%
Market Cap49.48M
Revenue(TTM)436.97M
Net Income(TTM)-35.62M
Analysts87.5
Price Target2.58 (519.3%)
Short Float %4.82%
Short Ratio5.24
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-63.4%
Min EPS beat(2)-128.76%
Max EPS beat(2)1.96%
EPS beat(4)2
Avg EPS beat(4)-35.2%
Min EPS beat(4)-128.76%
Max EPS beat(4)80.39%
EPS beat(8)5
Avg EPS beat(8)-37.59%
EPS beat(12)7
Avg EPS beat(12)-47.14%
EPS beat(16)10
Avg EPS beat(16)-37.27%
Revenue beat(2)1
Avg Revenue beat(2)0.1%
Min Revenue beat(2)-0.61%
Max Revenue beat(2)0.82%
Revenue beat(4)3
Avg Revenue beat(4)2.65%
Min Revenue beat(4)-0.61%
Max Revenue beat(4)9.35%
Revenue beat(8)6
Avg Revenue beat(8)1.43%
Revenue beat(12)8
Avg Revenue beat(12)1.25%
Revenue beat(16)10
Avg Revenue beat(16)0.89%
PT rev (1m)-34.84%
PT rev (3m)-34.84%
EPS NQ rev (1m)10%
EPS NQ rev (3m)-125%
EPS NY rev (1m)-14%
EPS NY rev (3m)-14%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.67%
Revenue NY rev (1m)-5.04%
Revenue NY rev (3m)-5.04%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.11
P/FCF N/A
P/OCF 10.88
P/B 0.93
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.26
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0.04
OCFY9.19%
SpS3.68
BVpS0.45
TBVpS-0.18
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.95%
ROE -66.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.83%
FCFM N/A
ROA(3y)-1.87%
ROA(5y)-1.61%
ROE(3y)-17.92%
ROE(5y)-14.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)1.6%
ROCE(5y)3.12%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.19%
OM growth 5Y-12.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.86%
GM growth 5Y-3.89%
F-Score4
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 2.34
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 102.78%
Cap/Sales 1.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.47
Quick Ratio 0.71
Altman-Z -0.5
F-Score4
WACC7.63%
ROIC/WACCN/A
Cap/Depr(3y)136.79%
Cap/Depr(5y)106.47%
Cap/Sales(3y)1.52%
Cap/Sales(5y)1.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-418%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-650%
EPS Next Y-902.41%
EPS Next 2Y-92.17%
EPS Next 3Y83.91%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.57%
Revenue growth 3Y2.17%
Revenue growth 5Y3.67%
Sales Q2Q%-11.99%
Revenue Next Year-2.54%
Revenue Next 2Y0.96%
Revenue Next 3Y2.02%
Revenue Next 5YN/A
EBIT growth 1Y-281.24%
EBIT growth 3Y-1.09%
EBIT growth 5Y-8.91%
EBIT Next Year181.28%
EBIT Next 3Y102.89%
EBIT Next 5YN/A
FCF growth 1Y-134.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-77.07%
OCF growth 3YN/A
OCF growth 5YN/A

ACCURAY INC / ARAY Fundamental Analysis FAQ

What is the fundamental rating for ARAY stock?

ChartMill assigns a fundamental rating of 1 / 10 to ARAY.


What is the valuation status for ARAY stock?

ChartMill assigns a valuation rating of 1 / 10 to ACCURAY INC (ARAY). This can be considered as Overvalued.


How profitable is ACCURAY INC (ARAY) stock?

ACCURAY INC (ARAY) has a profitability rating of 1 / 10.


Can you provide the financial health for ARAY stock?

The financial health rating of ACCURAY INC (ARAY) is 1 / 10.